Memory Stocks Surge, Early xAI & SpaceX Investor Peter Diamandis, Teva Pharma CEO 4/29/26 episode artwork

EPISODE · Apr 29, 2026 · 43 MIN

Memory Stocks Surge, Early xAI & SpaceX Investor Peter Diamandis, Teva Pharma CEO 4/29/26

from CNBC’s “Money Movers” · host CNBC

What does the surge in memory stocks signal about the broader AI trade? A look at those moves, ahead of four Mag 7 earnings reports tonight. Then early SpaceX and xAI investor Peter Diamandis on Elon Musk’s lawsuit against OpenAI. Plus, how to value a SpaceX IPO. And the CEO of Teva Pharma after reporting an earnings beat and announcing its first acquisition in a decade. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Apr 29, 2026

Embed this episode

NOW PLAYING

Memory Stocks Surge, Early xAI & SpaceX Investor Peter Diamandis, Teva Pharma CEO 4/29/26

0:00 43:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of CNBC’s “Money Movers”?

This episode is 43 minutes long.

When was this CNBC’s “Money Movers” episode published?

This episode was published on April 29, 2026.

Can I download this CNBC’s “Money Movers” episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!